Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kie-Kian Ang

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Seminars in Radiation Oncology|March 6, 2012
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinomaKie Kian Ang, Erich M Sturgis
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 31, 2006
Acceleration of normal-tissue damage expression by early stimulation of cell proliferation in rat spinal cordCarsten Nieder, Nicolaus Andratschke, Roger E Price, et al.
Head & Neck|December 25, 2008
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinomaAndre A Konski, Kathryn Winter, Bernard F Cole, et al.
Head & Neck|November 16, 2005
Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03Rachel Rabinovitch, Barbara Grant, Brian A Berkey, et al.
Cancer Treatment Reviews|November 2, 2013
Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directionsSandra Schmitz, Kie Kian Ang, Jan Vermorken, et al.
Head & Neck|September 4, 2007
Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckSharon A Spencer, Jonathan Harris, Richard H Wheeler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expressionVikas Bhardwaj, Yanai Zhan, Maria Angelica Cortez, et al.
Rays|March 17, 2004
Uncertainties in physical and biological targeting with radiation therapyJames D Cox, Naomi R Schechter, Andrew K Lee, et al.
Cancer Medicine|October 31, 2014
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefitUma Raju, David P Molkentine, David R Valdecanas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2014
EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324Ritsuko Komaki, Rebecca Paulus, George R Blumenschein, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Seminars in Radiation Oncology|March 6, 2012
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinomaKie Kian Ang, Erich M Sturgis
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 31, 2006
Acceleration of normal-tissue damage expression by early stimulation of cell proliferation in rat spinal cordCarsten Nieder, Nicolaus Andratschke, Roger E Price, et al.
Head & Neck|December 25, 2008
Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinomaAndre A Konski, Kathryn Winter, Bernard F Cole, et al.
Head & Neck|November 16, 2005
Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03Rachel Rabinovitch, Barbara Grant, Brian A Berkey, et al.
Cancer Treatment Reviews|November 2, 2013
Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directionsSandra Schmitz, Kie Kian Ang, Jan Vermorken, et al.
Head & Neck|September 4, 2007
Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckSharon A Spencer, Jonathan Harris, Richard H Wheeler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expressionVikas Bhardwaj, Yanai Zhan, Maria Angelica Cortez, et al.
Rays|March 17, 2004
Uncertainties in physical and biological targeting with radiation therapyJames D Cox, Naomi R Schechter, Andrew K Lee, et al.
Cancer Medicine|October 31, 2014
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefitUma Raju, David P Molkentine, David R Valdecanas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 22, 2014
EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324Ritsuko Komaki, Rebecca Paulus, George R Blumenschein, et al.
Pageof 3